ADMA Biologics (ADMA) News Today $19.04 -1.16 (-5.74%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Statutory Profit Doesn't Reflect How Good ADMA Biologics' (NASDAQ:ADMA) Earnings AreNovember 17 at 4:42 AM | finance.yahoo.comEntropy Technologies LP Acquires Shares of 37,850 ADMA Biologics, Inc. (NASDAQ:ADMA)Entropy Technologies LP acquired a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 37,850 shares of the biotechnology company's stock, valuNovember 15 at 4:27 AM | marketbeat.comState of New Jersey Common Pension Fund D Lowers Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)State of New Jersey Common Pension Fund D cut its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 42.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 113,607 shaNovember 15 at 3:43 AM | marketbeat.comJanney Montgomery Scott LLC Acquires Shares of 72,729 ADMA Biologics, Inc. (NASDAQ:ADMA)Janney Montgomery Scott LLC bought a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 72,729 shares of the biotechnoNovember 15 at 3:14 AM | marketbeat.comAigen Investment Management LP Invests $583,000 in ADMA Biologics, Inc. (NASDAQ:ADMA)Aigen Investment Management LP bought a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 29,143 shares of the bNovember 14 at 5:27 AM | marketbeat.comPrincipal Financial Group Inc. Buys 1,059,394 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Principal Financial Group Inc. raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 785.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,194,221 shares of the biotechnology company'November 14 at 3:20 AM | marketbeat.comAmalgamated Bank Has $1.36 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Amalgamated Bank raised its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 803.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 68,169 shares of the biotechnology company's stock after pNovember 14 at 3:19 AM | marketbeat.comLos Angeles Capital Management LLC Has $2.97 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)Los Angeles Capital Management LLC lifted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 83.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,490 shares of theNovember 13, 2024 | marketbeat.comADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the FirmNovember 12, 2024 | globenewswire.comFY2024 EPS Estimates for ADMA Biologics Raised by AnalystNovember 12, 2024 | americanbankingnews.comMesirow Financial Investment Management Inc. Reduces Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Mesirow Financial Investment Management Inc. decreased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 49.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,447 shares of thNovember 12, 2024 | marketbeat.comHC Wainwright Boosts ADMA Biologics (NASDAQ:ADMA) Price Target to $26.00November 12, 2024 | americanbankingnews.comStock Traders Buy Large Volume of ADMA Biologics Call Options (NASDAQ:ADMA)ADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) saw unusually large options trading activity on Monday. Stock investors purchased 11,474 call options on the stock. This is an increase of 539% compared to the average volume of 1,797 call options.November 11, 2024 | marketbeat.com235,035 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Purchased by Lisanti Capital Growth LLCLisanti Capital Growth LLC purchased a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 235,035 shares of the bioteNovember 11, 2024 | marketbeat.comHC Wainwright Forecasts Higher Earnings for ADMA BiologicsADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) - Investment analysts at HC Wainwright boosted their FY2024 EPS estimates for ADMA Biologics in a report issued on Friday, November 8th. HC Wainwright analyst R. Selvaraju now expects that the biotechnology company will earn $0.55 per share for theNovember 11, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week High on Analyst UpgradeNovember 10, 2024 | americanbankingnews.comADMA Biologics (NASDAQ:ADMA) Given New $25.00 Price Target at Raymond JamesNovember 10, 2024 | americanbankingnews.comKirby McInerney LLP Reminds ADMA Biologics, Inc. (ADMA) Investors of Shareholder InvestigationNovember 9, 2024 | businesswire.comRobeco Institutional Asset Management B.V. Increases Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Robeco Institutional Asset Management B.V. lifted its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 61.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 179,084 shares of the biotechnology compaNovember 9, 2024 | marketbeat.comNew York State Teachers Retirement System Acquires New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA)New York State Teachers Retirement System bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 91,114 shares of the biotechnology company's stock,November 9, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Price Target Raised to $26.00HC Wainwright lifted their price target on ADMA Biologics from $18.00 to $26.00 and gave the stock a "buy" rating in a research note on Friday.November 8, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Stock Price Expected to Rise, Raymond James Analyst SaysRaymond James raised their target price on ADMA Biologics from $18.00 to $25.00 and gave the company a "strong-buy" rating in a research report on Friday.November 8, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Sets New 52-Week High - Still a Buy?ADMA Biologics (NASDAQ:ADMA) Hits New 12-Month High - Here's WhyNovember 8, 2024 | marketbeat.comADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law FirmNovember 8, 2024 | prnewswire.comADMA INVESTOR NEWS: ADMA Biologics Investors with Losses May have been Affected by Fraud; Contact BFA Law (Nasdaq:ADMA)November 8, 2024 | globenewswire.comAdma Biologics options imply 13.3% move in share price post-earningsNovember 8, 2024 | markets.businessinsider.comAdma Biologics reports Q3 EPS 15c, consensus 13cNovember 8, 2024 | markets.businessinsider.comADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business UpdateNovember 8, 2024 | finance.yahoo.comADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income SurgeNovember 8, 2024 | finance.yahoo.comADMA Biologics, Inc. (ADMA) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comADMA Biologics Inc (ADMA) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 6, 2024 | finance.yahoo.comADMA STOCK REPORT: ADMA Biologics Investors are Notified to Contact BFA Law about the Securities Fraud Investigation after Stock Drops 20%November 6, 2024 | globenewswire.comKirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA)November 5, 2024 | businesswire.com3 US Stocks That May Be Trading Below Estimated ValueNovember 5, 2024 | finance.yahoo.comADMA INQUIRY ALERT: BFA Law Announces ADMA Biologics is being Investigated for Securities Fraud and Urges Investors to Contact the FirmNovember 5, 2024 | markets.businessinsider.comADMA Biologics, Inc. (NASDAQ:ADMA) Holdings Increased by Roman Butler Fullerton & Co.Roman Butler Fullerton & Co. increased its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 241.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,626 shares of the biotechnology coNovember 4, 2024 | marketbeat.comADMA INQUIRY ALERT: A Securities Fraud Investigation has been Initiated against ADMA Biologics into the Auditor Resignation; Investors with Losses are Urged to Contact the Firm (Nasdaq:ADMA)November 4, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMANovember 2, 2024 | prnewswire.comADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting DebacleNovember 2, 2024 | msn.comBFA Law is Investigating ADMA BIOLOGICS for Securities Fraud after Stock Plummets 20%; Contact the Firm if You Suffered Losses (Nasdaq:ADMA)November 2, 2024 | globenewswire.comADMA Biologics (NASDAQ:ADMA) Shares Gap Up - Here's What HappenedADMA Biologics (NASDAQ:ADMA) Shares Gap Up - What's Next?November 1, 2024 | marketbeat.comRice Hall James & Associates LLC Decreases Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Rice Hall James & Associates LLC lowered its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 63.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 418,036 shares of the biotechnology company's stock after selling 739,219 sharNovember 1, 2024 | marketbeat.comAdma Biologics reaches deal with KPMG to serve as auditorOctober 31, 2024 | markets.businessinsider.comADMA Biologics (ADMA) Set to Announce Earnings on ThursdayADMA Biologics (NASDAQ:ADMA) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=641693)October 31, 2024 | marketbeat.comADMA INVESTIGATION: ADMA Biologics Investors with Losses are Notified to Contact BFA Law about Ongoing Securities Fraud Investigation into Auditor Resignation (Nasdaq:ADMA)October 31, 2024 | globenewswire.comLouisiana State Employees Retirement System Makes New $2.25 Million Investment in ADMA Biologics, Inc. (NASDAQ:ADMA)Louisiana State Employees Retirement System bought a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 112,700 shares of the biotechnology company's stock, valued at approximatelyOctober 30, 2024 | marketbeat.comADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024October 29, 2024 | globenewswire.comADMA INVESTIGATION NOTICE: ADMA Biologics Stock Plummets 20% after Auditor Resigns; Investors are Notified to Contact BFA Law (Nasdaq:ADMA)October 29, 2024 | globenewswire.comADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the FirmOctober 28, 2024 | businesswire.comADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the FirmOctober 27, 2024 | globenewswire.com Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover ADMA Media Mentions By Week ADMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMA News Sentiment▼0.790.56▲Average Medical News Sentiment ADMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMA Articles This Week▼196▲ADMA Articles Average Week Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SLDB News CSBR News BGNE News MRNA News TEVA News SMMT News GMAB News VTRS News PCVX News RDY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
